| 000 | 01716 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516002741.0 | ||
| 264 | 0 | _c20110307 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1699-3055 | ||
| 024 | 7 |
_a10.1007/s12094-010-0566-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSánchez-Muñoz, Alfonso | |
| 245 | 0 | 0 |
_aOptimal adjuvant hormonal therapy in postmenopausal women with hormone-receptor-positive early breast cancer: have we answered the question? _h[electronic resource] |
| 260 |
_bClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico _cSep 2010 |
||
| 300 |
_a614-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAromatase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Progesterone _xmetabolism |
| 650 | 0 | 4 |
_aTamoxifen _xadministration & dosage |
| 700 | 1 | _aRibelles, Nuria | |
| 700 | 1 | _aAlba, Emilio | |
| 773 | 0 |
_tClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico _gvol. 12 _gno. 9 _gp. 614-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12094-010-0566-9 _zAvailable from publisher's website |
| 999 |
_c20182142 _d20182142 |
||